Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Ningxia Center for Disease Control and Prevention | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Prof. Dr. Wu Zhonglan's academic journey is marked by excellence and global engagement. Currently pursuing her PhD in Pathogen and Host Immunology, she laid a strong foundation with earlier distinctions that shaped her scientific career. Her selection for the National Scholarship enabled a year of advanced study at the QIMR Berghofer Medical Research Institute in Australia (2017–2018), reflecting both national confidence and international potential in her research acumen.

💼 Professional Endeavors

Prof. Wu serves as Chief of the Virus Section at the CDC and a Postgraduate Supervisor at Ningxia Medical University, underscoring her pivotal role in both research and mentorship. She holds influential appointments across national committees, including:

  •  ➤ Director, National AIDS Prevention and Control Association

  •  ➤ Member, National AIDS Testing Committee

  •  ➤ Member, National Microbial Sequencing Technical Committee

  •  ➤ Member, Ningxia Immunology Society

  •  ➤ Editorial Board Member, Journal of Phenomics

Her leadership spans laboratory diagnostics, public health strategy, and national policy.

🔬 Contributions and Research Focus

Prof. Wu’s scientific contributions are rooted in two major domains:

🦠 Viral Pathogen Research:
She has been at the forefront of utilizing Next-Generation Sequencing (NGS) technology for viral traceability—particularly for COVID-19 and monkeypox. Her innovative development of rapid screening platforms for unexplained pneumonia pathogens has strengthened epidemic preparedness and public health surveillance.

🧬 AIDS Molecular Epidemiology:
Prof. Wu is a key figure in HIV research in China. Her work involves constructing molecular transmission networks, analyzing HIV drug resistance, and refining HIV-RNA and HIV-DNA diagnostic technologies for improved treatment strategies and epidemiological tracing. She has successfully led 8 major research projects funded by the Natural Science Foundationreturnee innovation grants, and key R&D initiatives in Ningxia.

🏆 Accolades and Recognition

Prof. Wu has garnered widespread acclaim, including:

  •  ➤ National Public Health Leading Talent Program (2024)

  •  ➤ “Advanced Worker” of the Autonomous Region (2025)

  •  ➤ Ningxia Young Top Talent Cultivation Program (2017)

Her team’s achievements have been celebrated with:

  •  ➤ Third Prize for Scientific and Technological Progress (2019, 2023)

  •  ➤ Second Prize and two Third Prizes of the Ningxia Medical Science and Technology Awards

🌍 Impact and Influence

Through her pioneering work in pathogen genomics and HIV epidemiology, Prof. Wu has enhanced both regional and national capacities in disease control. Her influence extends into policy-making, health strategy design, and next-generation diagnostics. She is a role model for women in science, especially in traditionally male-dominated public health and molecular virology sectors.

📚 Legacy and Future Contributions

Prof. Wu has authored over 60 high-impact publications, with 14 SCI-indexed papers—one boasting an impact factor of 11.39. More than 10 papers have earned Outstanding Paper Awards in Ningxia, reflecting her consistent excellence in scientific communication. Looking ahead, Prof. Wu is poised to further shape China’s viral disease research landscape through integrative genomics, real-time diagnostics, and transdisciplinary collaborations. Her legacy will be defined not only by her discoveries but by the generations of researchers she continues to inspire.

Publications


📄  Sequencing of One Unique Recombinant CRF85_BC/CRF01_AE Genome and Two Partial Genomes from Ningxia, China

Authors: Li Y, Pei J, Zhu X, Liu Y, Ma X, Yang D, Wu Z
Journal: Viruses
Year: 2025


📄  HIV-1 Drug Resistance and Genetic Transmission Networks Among Patients with Sexually Transmitted HIV in Ningxia, China

Authors: Pei J, Wu Z, Si B, Ma C, Liu Y, Ma X, Kuai W, Zhang Y, Li Y
Journal: Frontiers in Public Health
Year: 2025


📄  Epidemiological and Spatial Analysis of Newly Diagnosed HIV-1/AIDS Patients Before Antiretroviral Therapy in Ningxia from 2020 to 2021

Authors: Liu Y, Ma X, Pei J, Yang D, Li Y, Zhu X, Wu Z
Journal: PLOS ONE
Year: 2025


📄  Epidemiological and Spatiotemporal Analysis of Elderly HIV-1/AIDS Patients in Ningxia, China, from 2018 to 2023

Authors: Wu Z, Liu Y, Ma X, Li Y, Zhu X, Yang D, Pei J, Li Y
Journal: Scientific Reports
Year: 2025


📄  Molecular Epidemiology of Hepatitis C Infections in Ningxia, China: Genotype, Phylogeny and Mutation Analysis

Authors: Wu Z, Cui L, Zhao W, Yang D, Chen H, Wang R, Wang X, Zhang L, He T
Journal: Virology Journal
Year: 2016


Adam Kern | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Adam Kern | Medicine and Dentistry | Best Researcher Award

University of Warmia and Mazury | Poland

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Adam Kern’s journey into medicine began with his M.D. from the Medical University in Gdańsk in 1995, followed by a Ph.D. from the Medical University of Poznań in 2005. In 2019, he achieved the title of Associate Professor from the University of Warmia and Mazury, where his academic and clinical pursuits have continued to flourish. His early dedication laid a strong foundation for his future contributions in cardiology.

🏥 Professional Endeavors

Dr. Kern currently serves as an Associate Professor in the Department of Cardiology and Internal Medicine at the University of Warmia and Mazury, and as Head of the Cardiac Catheterization Laboratory at Voivodal Specialist Hospital in Olsztyn, Poland. With a career spanning over two decades, he has held various positions from Resident to Senior Assistant and now leads invasive cardiology in both academic and clinical settings. He has overseen over 10,000 coronary angiograms and 5,000 PCIs, marking his role as one of the country’s most experienced interventional cardiologists.

🔬 Contributions and Research Focus

Dr. Kern's research focuses on interventional cardiology, coronary artery bifurcation lesions, and electrotherapy. He has led or contributed to key clinical trials including TRITON TIMI-38, TWILIGHT, POLBOS LM, and PLATO. His doctoral and habilitation work tackled critical aspects of ST-segment elevation ACS and distal left main stem coronary lesions, contributing valuable insights to clinical cardiology.

📚 Scientific Achievements

With 116 published articles, including 54 in Impact Factor journals, Dr. Kern’s academic work has a cumulative impact factor of 150.407 and H-index of 9. His work has been cited 316 times, affirming his role as a respected contributor in cardiovascular medicine. He regularly presents at national and international cardiology conferences, sharing case studies, complication management insights, and advanced techniques.

👨‍🏫 Teaching and Mentorship

Dr. Kern is a passionate educator, training medical students, junior doctors, and interventional cardiologists in pacemaker implantation, angiography, and PCI. His leadership extends to organizing annual country-wide cardiology workshops in Olsztyn and delivering over 10 lectures a year to regional consultants and general practitioners.

🏆 Accolades and Recognition

Dr. Kern’s exceptional service has earned him numerous honors, including:

  • ➤"Best of the Best" Laurel by the Marshal of Warmia and Mazury (2017)

  • ➤Individual Scientific Award from the Rector of UWM (2019)

  • ➤"Meritorious Medical Doctor of Warmia and Mazury" (2020)

  • ➤"Icon of Olsztyn Medicine" (2022)
    These accolades recognize both his scientific merit and his influence in promoting regional healthcare excellence.

🌍 Impact and Influence

As a Fellow of the European Society of Cardiology (FESC) and an active member of EHRA and EAPCI, Dr. Kern's influence reaches beyond Poland. His leadership in structuring primary PCI programs, purchasing and selecting interventional equipment, and mentoring new cardiologists has shaped the cardiology landscape in Warmia and Mazury.

🔮 Legacy and Future Contributions

Dr. Adam Kern continues to build a legacy of clinical precision, academic excellence, and community leadership. His deep involvement in research, combined with a hands-on role in saving lives through interventional procedures, ensures his future contributions will continue to elevate cardiovascular care both nationally and internationally. His leadership in teaching and innovation makes him a guiding force for future cardiologists.

Publications


📄 Kynurenine as a Predictor of Long-Term Mortality: A 10-Year Follow-Up from the KORONEF Registry
Journal: Biomedicines
Year: 2025
Authors: Adam Kern, Tomasz Stompór, Krystian Bojko, Ewa Sienkiewicz, Sebastian Pawlak, Krystyna Pawlak, Dariusz Pawlak, Grzegorz Poskrobko, Ewa Andrasz, Leszek Gromadziński, et al.


📄 Fractal Laws for Bifurcation Quantitative Coronary Angiography to Assess Left Main Bifurcation Lesions
Journal: Cardiology Research and Practice
Year: 2025 
Authors: Mattia Lunardi, Nozomi Kotoku, Carlo Briguori, Luc Maillard, Adam Kern, Franck Digne, Jacek Legutko, Maciej Lesiak, Adam Witkowski, Thierry Lefèvre, et al.


📄 Comparative Ten-Year Outcomes in Chronic and Acute Coronary Syndrome Patients Undergoing Invasive Diagnostics—Insights from the KORONEF Registry
Journal: Biomedicines
Year: 2024
Authors: Adam Kern, Tomasz Stompór, Krystian Bojko, Ewa Sienkiewicz, Sebastian Pawlak, Krystyna Pawlak, Dariusz Pawlak, Grzegorz Poskrobko, Ewa Andrasz, Leszek Gromadziński, et al.


📄 Percutaneous Coronary Interventions with Sirolimus-Eluting Alex Plus Stents in Patients with or without Diabetes: 4-Year Results
Journal: Journal of Cardiovascular Development and Disease
Year: 2024
Authors: Jacek Bil, Maciej Tyczynski, Adam Kern, Krystian Bojko, Robert J. Gil


Abdelaziz Ghanemi | Medicine and Dentistry | Best Researcher Award

Dr. Abdelaziz Ghanemi | Medicine and Dentistry | Best Researcher Award

Laval University | Canada

Author Profile

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Abdelaziz Ghanemi’s academic foundation reflects both intellectual rigor and global engagement. He graduated as the top student from the pharmacy program at Mentouri University of Constantine in Algeria. His quest for advanced scientific knowledge led him to China Pharmaceutical University, where he earned a Master of Science in Pharmacology, completing more than twice the credit requirement. His research there involved high-throughput screening for dopamine D5 receptor ligands—a project using transgenic cell lines and cutting-edge fluorescence assays. He then pursued a Ph.D. in Molecular Medicine at Laval University in Canada. His doctoral thesis was a comprehensive study of gene regulation in obesity and exercise, particularly focusing on TFF2 and SPARC, and was constructed from an impressive 27 peer-reviewed publications, marking an extraordinary achievement in biomedical research.

🧪 Professional Endeavors

Dr. Ghanemi’s professional journey spans Algeria, China, and Canada, covering a spectrum of scientific, academic, and community roles. His appointments include:

👨‍🔬 Postdoctoral Fellowships at CHU de Québec–Université Laval Research Center and LOEX Regenerative Medicine Lab, where he explored obesity, vascular calcification, and 3D bioprinting for tissue engineering.
👨‍🏫 Visiting Scholar at the University of Victoria (2024), working under Prof. Stephanie Willerth on bioprinting applications in regenerative medicine.
🔬 Research Professional at the CHUQ’s Functional Genomics and SAGE platform, applying gene expression tools to decode metabolic and ageing pathways.
🌍 Interpreter and Science Communicator, fluent in Arabic, English, French, and Chinese, enhancing cross-cultural scientific collaboration.

In addition to these, Dr. Ghanemi has participated in numerous internships, including hospital pharmacy and neurobiology labs, and taught pharmacology in China—demonstrating both practical and pedagogical expertise.

🔬 Contributions and Research Focus

Dr. Ghanemi’s research covers some of the most pressing biomedical themes of our time:

🧠 Obesity and metabolism, focusing on gene-environment interactions and exercise-induced molecular changes
💪 Regenerative medicine, especially the roles of SPARC and TFF2 in ageing, obesity, and tissue repair
🧬 Genomic and transcriptomic analysis using transgenic animal models and advanced sequencing platforms
🩺 Chronic kidney disease and mineral bone disorders, examining vitamin D pathways and Wnt/β-catenin signaling

His scholarly productivity includes over 50 scientific articles, a Google Scholar h-index of 22, and contributions to high-impact journals such as Biomedicines, Metabolites, Biology, Medicines, and Cytokine.

🏅 Accolades and Recognition

Dr. Ghanemi’s excellence has been recognized globally:

🥇 “Best Student Award” during his undergraduate pharmacy studies
🏆 Oral Presentation Award at ICOMES & AOCO 2019 in Seoul for research on SPARC and exercise
🎓 Vanier Canada Graduate Scholarship Nominee, one of Canada’s most prestigious honors
💬 “Student Seminar Award” by CHU de Québec Research Center for outstanding research communication
🏅 “I Stand With Her” Award at the Women in Medicine Summit (Chicago), honoring his advocacy for women's health
🌍 Laval University Representative at the Canadian Student Health Research Forum (2021)

These distinctions underscore both the scientific value and societal impact of his work.

🌐 Impact and Influence

Dr. Ghanemi’s influence extends beyond the laboratory. His work on exercise mimetics, bioenergetics, and gene-environment crosstalk holds implications for public health, geriatrics, and personalized medicine. As an editor for a special issue in Biomedicines (2024–2025), he is shaping academic dialogue on metabolism and tissue engineering. His editorial contributions and published opinions have influenced how we view obesity, exercise biology, and post-COVID metabolic health. His multilingual ability and international collaborations make him a bridge between cultures and scientific communities.

🔮 Legacy and Future Contributions

Dr. Ghanemi's trajectory suggests a lasting legacy in translational medicine. His integration of molecular research, clinical relevance, and public health awareness positions him to advance therapeutic development in obesity, regenerative strategies, and age-related diseases. With current projects involving SPARC’s therapeutic applications, vascular biology, and bioprinted tissues, Dr. Ghanemi is at the vanguard of modern biomedical science. His commitment to publishing, mentoring, and interdisciplinary exploration signals continued contributions to global health and scientific progress.

Publications


📄 A Single Intraperitoneal Secreted Protein Acidic and Rich in Cysteine Injection in Mice Is Towards an Exercise-like Phenotype
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Biology
Year: 2025


📄 Obesity and Bone Mineral Density Protection Paradox in Chronic Kidney Disease: Secreted Protein Acidic and Rich in Cysteine as a Piece of the Puzzle?
Authors: Abdelaziz Ghanemi, Fabrice Mac-Way
Journal: Life
Year: 2023


📄 Secreted Protein Acidic and Rich in Cysteine (SPARC) to Manage Coronavirus Disease-2019 (COVID-19) Pandemic and the Post-COVID-19 Health Crisis
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Medicines
Year: 2023


📄 Secreted Protein Acidic and Rich in Cysteine (SPARC)—Mediated Exercise Effects: Illustrative Molecular Pathways against Various Diseases
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Diseases
Year: 2023


📄 DNA Damage as a Mechanistic Link between Air Pollution and Obesity?
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Medicines
Year: 2022


Yash Brahmbhatt | Dentistry | Best Researcher Award

Mr. Yash Brahmbhatt | Dentistry | Best Researcher Award

Tufts University School of Dental Medicine | United States

Author Profile

Orcid

🎓 Early Academic Pursuits

Mr. Yash Brahmbhatt’s journey in education began with the International Baccalaureate® Career-related Programme at Atlantic High School, where he laid a solid foundation in health sciences and leadership. He pursued a Bachelor of Science in Public Health at Nova Southeastern University, complementing it with minors in Experiential Leadership and Pre-Health. His academic journey reached new heights when he enrolled in the Doctor of Medicine in Dentistry (DMD) program at Tufts University School of Dental Medicine (TUSDM), where he is on track to graduate in May 2027. His early focus on interdisciplinary learning and public service laid the groundwork for a multifaceted professional career.

💼 Professional Endeavors

Mr. Brahmbhatt has held diverse roles across academia, research, leadership, and community engagement. At Tufts, he is actively involved as a Teaching Assistant in multiple dental courses and serves as President of the AI in Dental Research & Education Society. His professional experiences extend to being Vice President of the Dental Entrepreneurship Club, an Admissions Ambassador, and a Researcher at Tufts Medical Center, where he investigates critical issues in dentistry and public health. His leadership roles within national organizations such as ASDA and ADEA highlight his growing influence in dental education and policy.

🧠 Contributions and Research Focus

Yash’s research contributions are wide-ranging and impactful. His work includes studies on peri-implant diseases, the link between periodontitis and cognitive decline, and AI applications in healthcare, including machine learning, language models, and 3D scanning technology. His dedication to innovation is further demonstrated through his leadership in organizing symposia and advancing evidence-based implant dentistry. He is especially passionate about integrating artificial intelligence into dental practice and education, setting a new standard for the next generation of practitioners.

🏆 Accolades and Recognition

Throughout his academic and professional journey, Mr. Brahmbhatt has earned numerous recognitions, such as membership in the President’s 64 at Nova Southeastern University, leadership appointments in national dental associations, and his role as CEO of the Saving Smile Foundation. His certification portfolio—from HIPAA to OSHA—reflects a deep commitment to ethical and safe practices in healthcare. His honors and positions speak to his integrity, ambition, and the trust he has garnered across institutions.

🌍 Impact and Influence

Mr. Brahmbhatt’s influence goes beyond clinical and academic excellence. As a mission and service trip veteran, he has contributed to healthcare access in Guatemala, India, and underserved communities in Florida. Through community efforts and his foundation, he champions oral health equity, youth engagement, and environmental advocacy via his Seize The Sea organization. His multilingual abilities and cross-cultural competencies enhance his impact in global and local communities alike.

✨ Legacy and Future Contributions

With a unique blend of clinical skill, research innovation, entrepreneurial mindset, and community spirit, Mr. Brahmbhatt is shaping the future of dentistry. His continued work in AI integration, public health policy, and dental education reform positions him as a changemaker. Looking ahead, he is poised to lead transformative efforts in improving oral healthcare systems, fostering interdisciplinary collaborations, and inspiring the next generation of dental leaders. His legacy is one of service, science, and sustained impact.

Publications


📄 Association Between Ethylene Oxide Exposure and Complete Edentulism in United States Adults

Authors: Yash Brahmbhatt, Michelle Zak, Razan Alhajri, Noura Almulla, Sakeenah Alqallaf, Abdullah Alkandari, Shahad Alsaleh, Hend Alqaderi
Journal: Life
Year: 2025


📄 Association Between Severe Periodontitis and Cognitive Decline in Older Adults

Authors: Yash Brahmbhatt, Hend Alqaderi, Zahra Chinipardaz
Journal: Life
Year: 2024


Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Dr. Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Toronto Western Hospital, University of Toronto | Canada

Author Profile

Scopus

📚 Early Academic Pursuits

Dr. Fadi Kharouf's academic journey began with a passion for [his specialization], leading him to pursue rigorous studies in [his major] at [his university]. His early academic years were marked by exceptional dedication, laying the foundation for his future research and professional endeavors.

💼 Professional Endeavors

Dr. Kharouf's career spans across academia and industry, where he has made significant contributions as a [his position] at [his institution/organization]. His expertise in [specific areas of expertise] has led to groundbreaking advancements, positioning him as a key figure in [his field].

🔬 Contributions and Research Focus

With a deep focus on [his primary research areas], Dr. Kharouf has worked extensively on [specific research projects or innovations]. His work on [notable findings or methodologies] has been instrumental in shaping new perspectives in [his domain]. His research has not only expanded theoretical knowledge but also paved the way for practical applications in [relevant industries].

🏅 Accolades and Recognition

Dr. Kharouf's contributions have earned him numerous awards and honors, recognizing his excellence in research and innovation. His work has been published in prestigious journals, and he has been invited as a keynote speaker at major conferences, reflecting his influence and thought leadership.

🌍 Impact and Influence

Beyond academia, Dr. Kharouf's impact extends to mentoring young researchers, collaborating on international projects, and contributing to policy-making in [his field]. His ability to bridge the gap between research and real-world applications has made a lasting impact on [his industry or academic community].

🚀 Legacy and Future Contributions

As Dr. Kharouf continues to push the boundaries of knowledge, his legacy is defined by his commitment to excellence and innovation. His ongoing work promises to further revolutionize [his domain], inspiring future generations to follow in his footsteps.

Publications


  • 📄The association between cigarette smoking and radiographic progression in Psoriatic Arthritis

    • Authors: Fadi Kharouf, Hernán H. Maldonado-Ficco, Shangyi S. Gao, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis

    • Authors: Fadi Kharouf, Pankti P. Mehta, Shangyi S. Gao, Dafna D.D. Gladman, Vinod V. Chandran
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Degenerative Disc Disease In Young Adults With Psoriatic Arthritis

    • Authors: Fadi Kharouf, Shangyi S. Gao, D. Pereira, R.J. Cook, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Journal of Rheumatology
    • Year: 2025

  • 📄Updates on Recent Advances in the Therapy of Adult Psoriatic Disease

    • Authors: Fadi Kharouf, Dafna D.D. Gladman
    • Journal: Current Rheumatology Reviews
    • Year: 2025

  • 📄Lupus nephritis: Biomarkers

    • Authors: C. Dobrowolski, S.M. Lao, Fadi Kharouf, P.P. Croci, J. Wither, D.D. Gladman, L.W. Garcia, A. Jauhal, Z. Touma
    • Journal: Advances in Clinical Chemistry
    • Year: 2025

 

Bojan Miletic | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Bojan Miletic | Medicine and Dentistry | Best Researcher Award

University of Rijeka | Croatia

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 📚

Assoc. Prof. Dr. Bojan Miletic began his academic journey at the University of Rijeka, Croatia, where he studied medicine from 1986 to 1992. His early education laid a strong foundation for his diverse career in internal medicine, cardiology, and rehabilitation. After completing his medical degree, Dr. Miletic went on to specialize in internal medicine, cardiology, and geriatric rehabilitation through various educational institutions, including the Clinical Hospital Center Rijeka, the Lucerne Cantonal Hospital in Switzerland, and several other renowned centers across Europe. His rigorous training allowed him to acquire multiple certifications and broaden his expertise in interdisciplinary medicine.

Professional Endeavors 🏥

Dr. Miletic has a distinguished professional career, spanning over two decades in various hospitals and rehabilitation centers across Europe. He currently serves as an Associate Professor and Co-Head of the Department of Clinical Medical Sciences at the University of Rijeka, Croatia, where he engages in both student education and clinical research. Alongside his academic duties, he also works as a Specialist in Internal Medicine and Cardiology at Policlinic Primari in Rijeka and the General Hospital and Homeland War Veterans Hospital in Ogulin, Croatia. His work in clinical settings, including the establishment of new medical units, has contributed significantly to the field.

Throughout his career, Dr. Miletic held leadership roles at several prestigious institutions, including the Lucerne Cantonal Hospital in Switzerland, the Zurich Rehabilitation Center, and Herzpark Hardterwald in Germany. His roles ranged from Co-Head of Rehabilitation Centers to Head of Cardiac Rehabilitation Departments. He also contributed to the development of new rehabilitation centers, providing education and training to nurses, physiotherapists, and doctors.

Contributions and Research Focus 🔬

Dr. Miletic has made significant contributions to clinical research, particularly in the areas of geriatric rehabilitation, cardiology, and internal medicine. His work has addressed key health issues such as depression in the elderly, rehabilitation outcomes, and diagnostic challenges in internal medicine. Dr. Miletic’s research has resulted in numerous articles published in respected journals, such as Medicina, J Sport Rehabil, Lancet Oncol, and Int J Cardiol. His studies often focus on innovative treatment methods, diagnostic challenges, and interdisciplinary approaches to medicine, aiming to improve patient outcomes and healthcare practices across various specialties.

Accolades and Recognition 🏅

Dr. Miletic’s contributions to the medical field have not gone unnoticed. He has received several prestigious awards, including the Green Card for contributing to the development of a culture of respect and promotion of patients' rights by the Croatian Movement for the Patients' Rights. He has also been honored by the Croatian Medical Association for his merits in advancing the medical profession and his health and humanitarian efforts. His excellence in clinical research, education, and leadership has earned him recognition from various professional bodies.

Impact and Influence 🌍

With over 20 years of experience in clinical and academic settings, Dr. Miletic has profoundly impacted the fields of cardiology, internal medicine, and rehabilitation. His role in establishing new departments and hospitals has improved medical services and patient care. His international experience and collaborations across Europe have allowed him to influence healthcare practices and medical education in multiple countries. His ongoing participation in congresses, scientific activities, and as a member of numerous professional societies further amplifies his influence on the global medical community.

Legacy and Future Contributions 🔮

Dr. Miletic’s career is marked by his unwavering commitment to improving patient care, advancing medical research, and educating the next generation of healthcare professionals. His work in developing new rehabilitation centers and his leadership in clinical research will continue to shape the future of healthcare in Europe and beyond. As an active member of professional societies like the European Society of Cardiology and the European Society of Cardiovascular Imaging, Dr. Miletic is poised to make continued contributions to the medical field, ensuring that his legacy as a leader in cardiology, rehabilitation, and internal medicine endures for years to come.

Publications


  • 📄Depression and Its Effect on Geriatric Rehabilitation Outcomes in Switzerland’s Aging Population

      • Authors: Bojan Miletic, Antonia Plisic, Lejla Jelovica, Jan Saner, Marcus Hesse, Silvije Segulja, Udo Courteney, Gordana Starcevic-Klasan
      • Journal: Medicina
      • Year: 2025

  • 📄Icterus provoked by Echinococcus mimicking a tumor: A diagnostic challenge

      • Authors: Bojan Miletic, Yves Sutter, Elefteri Buset, Silvije Segulja, Marcus Hesse
      • Journal: Travel Medicine and Infectious Disease
      • Year: 2025

  • 📄The Physical Activity and Dietary Habits of Nursing Students

    • Authors: Željko Jovanović, Maja Šarić, Bojan Miletic
    • Journal: Medical Research Archives
    • Year: 2024

  • 📄Virtual reality in the education of instrumentation techniques for nurses/technicians

    • Authors: Marija Spevan, Željko Jovanović, Bojan Miletic
    • Journal: World of Health
    • Year: 2024

  • 📄Infarkt miokarda s elevacijom ST segmenta kao indikacija za hitan medicinski transport u Opću bolnicu Zadar

    • Authors: Slavica Balgavi, Silvije Šegulja, Bojan Miletic
    • Event: 27th Congress of Emergency Medicine with International Participation
    • Year: 2024

 

Alessandra Sala | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Alessandra Sala | Medicine and Dentistry | Best Researcher Award

IRCCS Policlinico San Donato | Italy

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Dr. Alessandra Sala’s academic journey began with her graduation from the International Medical Degree Program at Università Vita-Salute San Raffaele Milan in 2016, where she earned the highest distinction—110/110 cum Laude and special honors. Her groundbreaking experimental thesis on percutaneous techniques for functional tricuspid regurgitation set the stage for her illustrious career. She further honed her expertise during her Cardiovascular and Thoracic Surgery Residency and PhD studies, focusing on pivotal areas such as valve-sparing aortic root replacement and tricuspid valve regurgitation.

💼 Professional Endeavors

Dr. Sala has cultivated a stellar career in cardiovascular surgery, with full-time roles at leading institutions such as I.R.C.C.S. Policlinico San Donato and San Raffaele University Hospital. Her internships and professional experiences span renowned global hospitals, including Mount Sinai and Columbia University Medical Center in New York, and Glenfield Hospital in the UK. Her tenure reflects a consistent dedication to mastering advanced surgical techniques and implementing innovative solutions for complex cardiovascular conditions.

🔬 Contributions and Research Focus

Dr. Sala’s research embodies a commitment to advancing cardiovascular and thoracic surgery. Her contributions include over a dozen peer-reviewed publications in prestigious journals, addressing critical topics such as tricuspid valve regurgitation, mitral valve repair, and aortic root replacement. Her studies, including the TRI-SCORE validation and interventions for mitral and tricuspid regurgitation, have significantly influenced both clinical practices and academic discourse. Dr. Sala’s research has consistently sought to bridge theory and application, offering solutions that improve patient outcomes and surgical success rates.

🏆 Accolades and Recognition

Dr. Sala’s excellence has been recognized through her groundbreaking thesis work, certifications in advanced surgical techniques, and accolades for her contributions to medical science. Her research papers, often cited in international journals, have solidified her reputation as a leading expert in her field. Additionally, her contributions to books and global presentations underscore her role as a thought leader in cardiovascular medicine.

🌍 Impact and Influence

Dr. Sala’s impact extends beyond academia and surgery to include mentorship, international collaborations, and community service. Her volunteer work in Nepal and Tanzania highlights her dedication to global healthcare access. As an ambassador for Gap Medics, she inspires aspiring medical professionals to explore their potential in the field of medicine. Her innovative approach to digital and immersive technologies in surgery also positions her as a forward-thinking leader shaping the future of cardiovascular care.

✨ Legacy and Future Contributions

With her remarkable accomplishments in research, surgery, and mentorship, Dr. Sala is poised to continue driving advancements in cardiovascular and thoracic medicine. Her legacy is defined by a relentless pursuit of excellence, groundbreaking research, and a global perspective on healthcare. As she forges ahead, Dr. Sala will undoubtedly leave an indelible mark on the field, influencing both current and future generations of medical professionals.

 

Publications


📰 Valve-sparing versus Bio-Bentall Aortic Root Replacement in Patients Aged 60-75 Years: Survival, Reintervention, and Aortic Regurgitation

Authors: Alessandra Sala, Michele Di Mauro, Edoardo Zancanaro, Marta Bargagna, Francesco Grimaldi, Veronica D’Oria, Lorenzo Menicanti, Ottavio Alfieri, Michele De Bonis, Carlo de Vincentiis
Journal: The Annals of Thoracic Surgery
Year: 2025


📰A Novel Versatile Concept of Cardioplegia Delivery in Cardiac Surgery: The ReverseTWO Cardioplegia Circuit System

Authors: N. Colangelo, Alessandra Sala, G. Gallio, A. Blasio, F. De Simone, A. Aina, A. Buffa, A. Verzini, O. Alfieri, F. Maisano
Journal: Perfusion (United Kingdom)
Year: 2024


📰Bicuspid Aortic Valve, from the Unknown till the Perfection of the Species

Authors: M. Bargagna, G. Ascione, E. Zancanaro, F. Fioravanti, Alessandra Sala, C. Trumello, G. Chang, A. Verzini, A. Castiglioni, F. Maisano
Journal: Reviews in Cardiovascular Medicine
Year: 2024


📰Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

Authors: J. Dreyfus, M. Taramasso, K.-P. Kresoja, H. Omran, C. Iliadis, G. Russo, M. Weber, L. Nombela-Franco, R. Estevez Loureiro, J. Hausleiter, Alessandra Sala (et al.)
Journal: JACC: Cardiovascular Interventions
Year: 2024


📰TRI-SCORE and Benefit of Intervention in Patients with Severe Tricuspid Regurgitation

Authors: J. Dreyfus, X. Galloo, M. Taramasso, G. Heitzinger, G. Benfari, K.-P. Kresoja, F. Juarez-Casso, H. Omran, Y. Bohbot, C. Iliadis, Alessandra Sala (et al.)
Journal: European Heart Journal
Year: 2024


 

Dan Liu | Medicine and Dentistry | Best Researcher Award

Dr. Dan Liu | Medicine and Dentistry | Best Researcher Award

General Hospital of Ningxia Medical University | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Dan Liu began her distinguished journey with a strong foundation in medicine and research. Her academic rigor led her to advanced positions, including her role as a doctoral supervisor and principal investigator. She gained international exposure as a visiting scholar at the University of Iowa and Texas Medical Center, further enhancing her global perspective and expertise in medical sciences.

💼 Professional Endeavors

Currently, Dr. Liu serves as the director of the Ningxia Hysteroscopy Diagnosis and Treatment Center and plays a pivotal role at the General Hospital of Ningxia Medical University. Her leadership in hysteroscopy diagnostics has transformed the medical landscape in Ningxia. Beyond clinical duties, she actively drives innovation and research, influencing medical sciences both regionally and nationally.

🔬 Contributions and Research Focus

Dr. Liu's research portfolio is impressive, including two projects funded by the National Natural Science Foundation of China and one significant national-grade project. She has successfully integrated technological advancements into her field, holding one utility model patent and one invention patent. Her pioneering contributions address critical challenges in women’s health, making significant strides in hysteroscopy techniques and diagnostics.

🏆 Accolades and Recognition

Dr. Liu’s accomplishments have garnered numerous awards, such as the prestigious second prize of the Science and Technology Progress Award of Ningxia Autonomous Region. In 2023, her dedication and exceptional service earned her the "Special Contribution" Award from People’s Daily Online, recognizing her as an excellent doctor. These accolades underscore her impact on medical innovation and patient care.

🌟 Impact and Influence

Through her dual roles in clinical practice and academia, Dr. Liu has shaped the next generation of medical professionals while advancing the field of hysteroscopy. Her leadership in research and treatment has set new benchmarks, directly benefiting patients and fostering a culture of innovation in the medical community.

🔮 Legacy and Future Contributions

As a trailblazer in her field, Dr. Liu’s legacy is one of excellence and commitment to advancing healthcare. Her ongoing projects and visionary leadership promise continued contributions to medical science, inspiring future researchers and clinicians to follow her path of innovation and service.

 

Publications


📝 Meta-analysis of FOXP3 polymorphisms and recurrent spontaneous abortion susceptibility
Authors: Shuai, R., Li, D., Xu, X., Yang, X., Liu, D.
Journal: American Journal of Reproductive Immunology
Year: 2024


📝 The osteogenesis and the biologic mechanism of thermo-responsive injectable hydrogel containing carboxymethyl chitosan/sodium alginate nanoparticles towards promoting osteal wound healing
Authors: Shi, Z., Yang, F., Pang, Q., Zhu, Y.
Journal: International Journal of Biological Macromolecules
Year: 2023


📝 Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway
Authors: Yuan, L., Cao, J., Hu, M., Chen, M., Liu, D.
Journal: Reproductive Biology and Endocrinology
Year: 2022


📝 A novel intrauterine barrier for preventing the recurrence of IUA after TCRA procedure
Authors: Chen, M., Yuan, L., Jin, H., Zhang, X., Liu, D.
Journal: Medical Hypotheses
Year: 2022


📝 Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice
Authors: Zhang, H., Xu, D., Li, Y., Li, G., Liu, D.
Journal: International Journal of Biological Sciences
Year: 2022


 

Yanhua Wang | Medicine and Dentistry | Best Researcher Award

Dr. Yanhua Wang | Medicine and Dentistry | Best Researcher Award

Shanxi Aier Eye Hospital | China

Author Profile

Scopus

Orcid 

Early Academic Pursuits 📚

Dr. Yanhua Wang's journey in ophthalmology began with her Bachelor's degree in Clinical Medicine from Shanxi Changzhi Medical University in 1998. She pursued advanced studies, earning an MD in Ophthalmology and a PhD from Southwest Eye Hospital, General Medical University in Chongqing, China. Her academic trajectory was further enriched with a postdoctoral fellowship at the Department of Ophthalmology, General Hospital of PLA, Beijing, in 2013. This solid foundation equipped her with expertise in cutting-edge ophthalmic research and clinical care.

Professional Endeavors 💼

Dr. Wang's career spans over two decades, marked by her tenure as Deputy Chief Physician at Jinhzhong Hospital, Shanxi Province, where she served until 2016. Currently, she is the Chief Physician at the Department of Pediatric Ophthalmology & Optometry, Shanxi Aier Eye Hospital, part of the Aier Eye Hospital Group. Her role emphasizes innovative treatments and advanced care for pediatric ocular conditions, solidifying her as a leader in her field.

Contributions and Research Focus 🧠🔬

Dr. Wang’s research delves into the mechanisms underlying retinal neuron survival, optic nerve regeneration, and pediatric strabismus. Her studies on alpha-crystallin’s neuroprotective effects and its role in axonal regeneration have pioneered new therapeutic pathways. Through publications in journals such as Journal of Ophthalmology and Neuroscience Letters, she has significantly advanced understanding in these domains. She has also innovated patented technologies, including intelligent examination devices and surgical support structures, showcasing her dedication to translational research.

Accolades and Recognition 🏆

Dr. Wang has received numerous accolades, including the Chongqing Second Prize for Scientific and Technological Progress in 2013. She has secured major grants from prestigious institutions, such as the National Natural Science Foundation of China, the China Postdoctoral Science Foundation, and the Aier Eye Hospital Group Foundation. These honors reflect her impactful contributions to ophthalmology and translational medicine.

Impact and Influence 🌍

Dr. Wang’s work has had a profound influence on pediatric ophthalmology, offering novel diagnostic and therapeutic solutions for conditions like strabismus. Her patented inventions have enhanced clinical precision and patient outcomes, and her research has provided valuable insights into neuroprotection and nerve regeneration. Her leadership in clinical care and her scientific achievements continue to inspire and guide the next generation of ophthalmologists.

Legacy and Future Contributions 🌟

With her unwavering commitment to pediatric ophthalmology and groundbreaking research, Dr. Yanhua Wang's legacy is one of innovation and compassion. Her future contributions promise to bridge clinical advancements with cutting-edge research, ensuring better ocular health outcomes for children worldwide. Through her continued efforts, Dr. Wang is poised to leave an indelible mark on ophthalmology and medical science.

 

Publications


📝 Characteristics of Peripheral Retinal Refraction and Its Role in Children with Different Refractive States
Authors: Qi Zhao, Yanhua Wang*, Tiangang Liang, Weixiang Nie, Pei Xue, Jie Cheng
Journal: Journal of Ophthalmology
Year: 2024


📝 Synergistic Effect of Olfactory Ensheathing Cells and Alpha-Crystallin on Restoration of Adult Rat Optic Nerve Injury
Authors: Wang, Y.H., Yin, Z.Q., Wang, Y.
Journal: Neuroscience Letters
Year: 2017


📝 Leber's Hereditary Optic Neuropathy is Associated with Compound Primary Mutations of Mitochondrial ND1 m.3635G > A and ND6 m.14502 T > C
Authors: Jin, X., Wang, L., Gong, Y., Chen, T., Wei, S.
Journal: Ophthalmic Genetics
Year: 2015


📝 Alpha-Crystallin Promotes Rat Olfactory Ensheathing Cells Survival and Proliferation through Regulation of PI3K/Akt/mTOR Signaling Pathways
Authors: Wang, Y.H., Li, Y.C., Huo, S.J., Yin, Z.Q.
Journal: Neuroscience Letters
Year: 2012


📝 Alpha-Crystallin Promotes Rat Axonal Regeneration through Regulation of RhoA/Rock/Cofilin/MLC Signaling Pathways
Authors: Wang, Y.H., Wang, D.W., Wu, N., Wang, Y., Yin, Z.Q.
Journal: Journal of Molecular Neuroscience
Year: 2012


 

Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

Scopus

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

 

Publications


📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

  • Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
  • Journal: Nutrients
  • Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

  • Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
  • Journal: European Journal of Pharmaceutical Sciences
  • Year: 2024

📄  Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

  • Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
  • Journal: Drugs in R and D
  • Year: 2024

📄  Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

  • Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
  • Journal: PharmacoEconomics
  • Year: 2023

📄  Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

  • Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
  • Journal: Diseases of the Colon and Rectum
  • Year: 2022